Nib’s ‘insulting’ offer to members
Health funds pledged to return cash to members after making $1.8bn during Covid, but nib’s offer is far less generous compared to its competitors.
Our Journalists
Latest
New Covid freedoms will come with a catch
Eighty per cent vaccination rates won’t mean total freedom – experts reveal what living with Covid really looks like.
Rosie the robot saving Aussie breast cancer nurses
This robot, a human height iPad on wheels, is helping breast cancer nurses anywhere in Australia and their patients.
‘Live with it’: Gladys warns states as NSW records 681 cases
Gladys Berejiklian has warned states and territories they need to learn to live with the Delta variant, as NSW recorded 681 new cases and another death.
Shocking new breast cancer stat
Professor Nehmat Houssami has been given a daunting task- find a way to prevent this alarming breast cancer statistic from increasing.
How mixing AstraZeneca with Pfizer could strengthen immunity
One way to overcome vaccine hesitancy could be to promise Pfizer as a second jab to people who get AstraZeneca.
The suburbs lagging behind in vax rollout
As Australia’s Covid vaccine rollout gathers momentum, these Melbourne suburbs are lagging behind in jab uptake.
Covid vaccine delivery bungle hampers rollout
GPs and pharmacists are waiting two weeks for deliveries of Covid-19 vaccines, with health workers unable to keep up with demand for jabs.
7300 young Aussies in shock $146.5m Covid bill
Patients on ventilators are not the biggest cost for Australia’s health system. Another Covid crisis affecting young people is.
Why nasal sprays could be the answer to Delta
The key to suppressing Covid-9 could be in delivering the vaccine as a nasal spray or supplementing it with a nasal spray, scientists say.
Original URL: https://www.dailytelegraph.com.au/journalists/sue-dunlevy/page/52